Last updated: 15 June 2019 at 4:18pm EST

Eilon D. Kirson Net Worth




The estimated Net Worth of Eilon D. Kirson is at least $5.74 Million dollars as of 27 February 2019. Eilon Kirson owns over 6,945 units of NovoCure Ltd stock worth over $2,625,990 and over the last 9 years Eilon sold NVCR stock worth over $3,112,337.

Eilon Kirson NVCR stock SEC Form 4 insiders trading

Eilon has made over 18 trades of the NovoCure Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Eilon exercised 6,945 units of NVCR stock worth $367,391 on 27 February 2019.

The largest trade Eilon's ever made was exercising 346,161 units of NovoCure Ltd stock on 4 June 2018 worth over $2,468,128. On average, Eilon trades about 50,921 units every 40 days since 2016. As of 27 February 2019 Eilon still owns at least 152,408 units of NovoCure Ltd stock.

You can see the complete history of Eilon Kirson stock trades at the bottom of the page.



What's Eilon Kirson's mailing address?

Eilon's mailing address filed with the SEC is C/O NOVOCURE INC.,, 20 VALLEY STREAM PKWY SUITE 300, MALVERN, PA, 19355.

Insiders trading at NovoCure Ltd

Over the last 9 years, insiders at NovoCure Ltd have traded over $237,132,855 worth of NovoCure Ltd stock and bought 164,174 units worth $2,198,429 . The most active insiders traders include Asaf Danziger, William Fwfd Ventures Fund ... und Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of $853,350. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth $13,856.



What does NovoCure Ltd do?

we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.



What does NovoCure Ltd's logo look like?

NovoCure Ltd logo

Complete history of Eilon Kirson stock trades at NovoCure Ltd

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
27 Feb 2019 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 6,945 $52.90 $367,391
27 Feb 2019
152,408
22 Feb 2019 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 36,400 $53.38 $1,943,032
22 Feb 2019
145,463
16 Jan 2019 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 168,813 $14.37 $2,425,843
16 Jan 2019
177,876
13 Jun 2018 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 68,250 $12.77 $871,553
13 Jun 2018
107,832
4 Jun 2018 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 346,161 $7.13 $2,468,128
4 Jun 2018
160,447
18 Apr 2018 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 147,825 $3.44 $508,518
18 Apr 2018
110,538
22 Feb 2018 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 36,401 $21.55 $784,442
22 Feb 2018
39,582
11 Jan 2018 Eilon D. Kirson
Chief Scientific Officer
Verkauf 25,320 $22.00 $557,040
11 Jan 2018
3,181
6 Nov 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 9,100 $22.00 $200,200
6 Nov 2017
28,501
2 Nov 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 3,400 $22.00 $74,800
2 Nov 2017
37,601
31 Oct 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 22,269 $22.01 $490,141
31 Oct 2017
41,001
21 Jun 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 66,361 $16.78 $1,113,538
21 Jun 2017
222,722
19 Jun 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 15,000 $15.06 $225,900
19 Jun 2017
289,083
13 Jun 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 9,044 $15.01 $135,750
13 Jun 2017
304,083
9 Jun 2017 Eilon D. Kirson
Chief Scientific Officer
Verkauf 20,956 $15.03 $314,969
9 Jun 2017
313,127
5 Dec 2016 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 156,073 $0.17 $26,532
5 Dec 2016
334,083
5 Dec 2016 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 156,073 $0.17 $26,532
5 Dec 2016
334,083
18 Apr 2016 Eilon D. Kirson
Chief Scientific Officer
Optionausübung 29,565 $0.17 $5,026
18 Apr 2016
178,010


NovoCure Ltd executives and stock owners

NovoCure Ltd executives and other stock owners filed with the SEC include: